Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 qRT-PCR fold change comparison, disease vs CON, of splice vs no-splice primer sites qRT-PCR fold change comparison, disease vs CON, of splice.

Published byYulia Atmadja Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 3 qRT-PCR fold change comparison, disease vs CON, of splice vs no-splice primer sites qRT-PCR fold change comparison, disease vs CON, of splice."— Presentation transcript:

1 Figure 3 qRT-PCR fold change comparison, disease vs CON, of splice vs no-splice primer sites
qRT-PCR fold change comparison, disease vs CON, of splice vs no-splice primer sites Exon regions with expected alternative splicing activity are compared with flanking exon regions without predicted alternative splicing, “no-splice.” The dotted line indicates 100% inclusion (of a queried exon). CON = control; PD = Parkinson disease; PD-D = PD with dementia; qRT = quantitative real-time. Adrienne Henderson-Smith et al. Neurol Genet 2016;2:e75 © 2016 American Academy of Neurology

Download ppt "Figure 3 qRT-PCR fold change comparison, disease vs CON, of splice vs no-splice primer sites qRT-PCR fold change comparison, disease vs CON, of splice."

Similar presentations

Figure Pedigrees of the SCA42 families identified in this study

Figure Pedigrees of the SCA42 families identified in this study
Figure Cerebral MRI and molecular and enzymatic analysis

Figure Cerebral MRI and molecular and enzymatic analysis
Figure 1 Comparison of miR-150-5p (log scale), prednisone dose (mg), and QMG score between the thymectomy (ETTX) and prednisone groups Comparison of miR-150-5p.

Figure 1 Comparison of miR-150-5p (log scale), prednisone dose (mg), and QMG score between the thymectomy (ETTX) and prednisone groups Comparison of miR-150-5p.
Figure 2 FXTAS Rating Scale scores for case 1

Figure 2 FXTAS Rating Scale scores for case 1
Figure Pedigree of the family

Figure Pedigree of the family
Figure 2 Association between coronary artery disease polygenic risk score and the presence of migraine Results are given as odds ratios with 95% confidence.

Figure 2 Association between coronary artery disease polygenic risk score and the presence of migraine Results are given as odds ratios with 95% confidence.
Figure 3 Transcripts of the splicing mutation (c

Figure 3 Transcripts of the splicing mutation (c
Figure Increase of publications relating to genetics and neurology Pubmed was searched for the following advanced search term: (gene[Text Word]) OR mutation[Text.

Figure Increase of publications relating to genetics and neurology Pubmed was searched for the following advanced search term: (gene[Text Word]) OR mutation[Text.
Figure 2 Luciferase assays of transiently transfected HEK 293 cells with reporter constructs containing the 766-bp wild-type KCNJ18 or c.-542 T/A mutant.

Figure 2 Luciferase assays of transiently transfected HEK 293 cells with reporter constructs containing the 766-bp wild-type KCNJ18 or c.-542 T/A mutant.
Figure 1 8-Iso-PGF2α levels in CSF of patients with MS and controlsCSF 8-iso-prostaglandin F2α (8-iso-PGF2α) levels were estimated using an ELISA. (A)

Figure 1 8-Iso-PGF2α levels in CSF of patients with MS and controlsCSF 8-iso-prostaglandin F2α (8-iso-PGF2α) levels were estimated using an ELISA. (A)
Figure WDR45 sequence changes in patients A and B

Figure WDR45 sequence changes in patients A and B
Figure 3 Temporal trends in FALS incidence

Figure 3 Temporal trends in FALS incidence
Table 4 Associations in SNP array data between the Braak stage and previously known AD risk loci (341 variants) comparing participants with Braak stage.

Table 4 Associations in SNP array data between the Braak stage and previously known AD risk loci (341 variants) comparing participants with Braak stage.
Figure 1 Pedigrees of the early-onset Alzheimer disease families and SORL1 protein diagram Pedigrees of the early-onset Alzheimer disease families and.

Figure 1 Pedigrees of the early-onset Alzheimer disease families and SORL1 protein diagram Pedigrees of the early-onset Alzheimer disease families and.
Figure 1 SpliceSeq “splice graphs” for the 7 qRT-PCR tested genes

Figure 1 SpliceSeq “splice graphs” for the 7 qRT-PCR tested genes
Figure 1 Characteristics of the German National MS Cohort

Figure 1 Characteristics of the German National MS Cohort
Figure 2 Linkage analysis of chromosome 19

Figure 2 Linkage analysis of chromosome 19
Figure 1 Schematic overview of flow cytometry Schematic overview on the analysis of peripheral immune cells by flow cytometry. Schematic overview of flow.

Figure 1 Schematic overview of flow cytometry Schematic overview on the analysis of peripheral immune cells by flow cytometry. Schematic overview of flow.
Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.
Figure 2 Cerebral and spinal MRI (A) Restricted diffusion of both optic nerves (arrows) on diffusion-weighted and apparent diffusion coefficient imaging.

Figure 2 Cerebral and spinal MRI (A) Restricted diffusion of both optic nerves (arrows) on diffusion-weighted and apparent diffusion coefficient imaging.

Similar presentations

Ads by Google